Missing Script

Get updates

MS-N160 · Traditional Thai botanical · Oral mucositis support · Head-and-neck cancer · Randomized trial · Appraised 28 October 2026

Can a mucoadhesive fingerroot extract gargle reduce oral mucositis during concurrent chemoradiotherapy for head-and-neck cancer?

Evidence at a glance

  • Evidence label: Promising single-trial signal; abstract-limited appraisal
  • Benefit: A 56-person randomized study reported lower overall oral-mucositis incidence at week 6 with the extract gargle: 30.4% versus 41.1% (P=0.04).
  • Certainty: Low. The full article was not accessible for this appraisal; allocation details, analyzed denominators, mucositis-grade distribution and missing-data handling could not be fully verified.
  • Risk: Lip swelling was less frequent in the intervention group, and other reported adverse events were comparable, but uncommon allergy, irritation and contamination risks remain uncertain.

What was studied

Adults with head-and-neck cancer receiving concurrent chemoradiotherapy used a mucoadhesive mouth gargle formulated with Boesenbergia rotunda extract or were assigned to the study control. The clinical study ran from September 2024 through November 2025; adherence was 73.98%. The primary clinical outcome was oral-mucositis incidence at six weeks.

What the evidence found

Overall mucositis incidence was 30.4% with the extract gargle and 41.1% with control (P=0.04). Lip swelling at week 3 was 1.8% versus 14.3% (P=0.03); other adverse events were reported as comparable. The abstract does not establish whether severe mucositis, feeding-tube use, treatment interruptions, pain or opioid use improved.

How to interpret it

Fingerroot is a culinary and traditional medicinal plant in Thailand, but documented use is not proof of benefit. This formulation-specific supportive-care finding needs replication and full reporting. It does not show that fingerroot treats cancer or improves survival.

Practical safety context

Mucositis can lead to dehydration, malnutrition and infection. New fever, inability to drink, bleeding or uncontrolled pain needs prompt clinical assessment. Do not substitute a homemade botanical rinse for the tested mucoadhesive formulation; composition, sterility and mucosal exposure may differ.

Questions for the care team

  • What exactly was in the tested gargle, and is a quality-controlled equivalent available?
  • Did the trial reduce severe mucositis or treatment interruptions, not only any-grade incidence?
  • Could this product irritate damaged mucosa or interact with prescribed oral-care products?

Funding and conflicts

Funding and author conflicts were not verified from the accessible abstract. This limitation is material and should be revisited if full text becomes available.

Sources

Last literature search: 28 October 2026. Record appraisal: 28 October 2026. This page is educational and does not replace individualized medical advice. Symptom, biomarker or observational findings must not be interpreted as proof of tumor control, recurrence prevention or longer survival unless those outcomes were directly tested.